GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » E10

Thalys Medical Technology Group (SHSE:603716) E10 : ¥0.17 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Thalys Medical Technology Group's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.17 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-30), Thalys Medical Technology Group's current stock price is ¥10.83. Thalys Medical Technology Group's E10 for the quarter that ended in Sep. 2024 was ¥0.17. Thalys Medical Technology Group's Shiller PE Ratio of today is 63.71.

During the past 13 years, the highest Shiller PE Ratio of Thalys Medical Technology Group was 80.53. The lowest was 25.24. And the median was 41.65.


Thalys Medical Technology Group E10 Historical Data

The historical data trend for Thalys Medical Technology Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group E10 Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Thalys Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.21 0.17

Competitive Comparison of Thalys Medical Technology Group's E10

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Shiller PE Ratio falls into.


;
;

Thalys Medical Technology Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thalys Medical Technology Group's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.26/115.7848*115.7848
=-0.260

Current CPI (Sep. 2024) = 115.7848.

Thalys Medical Technology Group Quarterly Data

per share eps CPI Adj_EPS
201212 0.693 95.237 0.843
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201509 0.115 100.500 0.132
201512 0.146 100.600 0.168
201603 0.083 102.200 0.094
201606 0.189 101.400 0.216
201609 0.103 102.400 0.116
201612 0.107 102.600 0.121
201703 0.064 103.200 0.072
201706 0.126 103.100 0.142
201709 0.102 104.100 0.113
201712 0.216 104.500 0.239
201803 0.090 105.300 0.099
201806 0.200 104.900 0.221
201809 0.170 106.600 0.185
201812 0.112 106.500 0.122
201903 0.110 107.700 0.118
201906 0.169 107.700 0.182
201909 0.160 109.800 0.169
201912 0.110 111.200 0.115
202003 -0.120 112.300 -0.124
202006 0.160 110.400 0.168
202009 0.110 111.700 0.114
202012 0.138 111.500 0.143
202103 0.030 112.662 0.031
202106 -0.010 111.769 -0.010
202109 -0.012 112.215 -0.012
202112 -0.246 113.108 -0.252
202203 0.100 114.335 0.101
202206 -0.095 114.558 -0.096
202209 -0.033 115.339 -0.033
202212 -0.731 115.116 -0.735
202303 -0.070 115.116 -0.070
202306 0.081 114.558 0.082
202309 -0.026 115.339 -0.026
202312 -0.800 114.781 -0.807
202403 0.020 115.227 0.020
202406 -0.039 114.781 -0.039
202409 -0.260 115.785 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.


Thalys Medical Technology Group  (SHSE:603716) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Thalys Medical Technology Group's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=10.83/0.17
=63.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Thalys Medical Technology Group was 80.53. The lowest was 25.24. And the median was 41.65.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Thalys Medical Technology Group E10 Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines